Aberrant expression of vascular endothelial growth factor (VEGF) has been documented in diabetes, atherosclerosis, cancer metastasis, and inflammation, which contribute to the bulk of mortality and morbidity in man [113,114] (Figure 3). The gene discussed is VEGFA; the disease is cancer.